AstraZeneca is roundly rebuked by The Lancet in an editorial that
describes the firm's development of its new cholesterol-lowering
drug Crestor as a "triumph of marketing over science". Chief
executive Sir Tom McKillop...
October has seen a rush by US biotechnology companies to list on
the stock markets, bringing to an end an Initial Public Offering
(IPO) drought lasting more than 18 months. Is Europe destined to
Biotechnology company Biovitrum has established a new business
unit, Biovitrum Biopharmaceuticals, to strengthen its position as a
supplier of process development and contract manufacture of
recombinant proteins. The move follows...
BioProgress has started legal proceedings against Stanelco Fibre
Optics claiming ownership of several patents related to processes
used in gelatine-free encapsulation. Stanelco recently unveiled its
own ambitions in this area after...
The first grants have been awarded in the ENCODE program,an
extension of the Human Genome Project which is hoping to develop an
encyclopedia of function for all the sequences in the human genetic
map. A $35m pilot project aimed at...